Watts NB - Search Results

1

Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, Ferrari S. Watts NB, et al. Osteoporos Int. 2012 Jan;23(1):327-37. doi: 10.1007/s00198-011-1755-2. Epub 2011 Sep 3. Osteoporos Int. 2012. PMID: 21892677 Free PMC article. Clinical Trial.

2

Postmenopausal osteoporosis.

Watts NB. Watts NB. Obstet Gynecol Surv. 1999 Aug;54(8):532-8. doi: 10.1097/00006254-199908000-00024. Obstet Gynecol Surv. 1999. PMID: 10434274 Review.

3

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. Harris ST, et al. Among authors: watts nb. JAMA. 1999 Oct 13;282(14):1344-52. doi: 10.1001/jama.282.14.1344. JAMA. 1999. PMID: 10527181 Clinical Trial.

4

Clinical use of biochemical markers of bone remodeling: current status and future directions.

Looker AC, Bauer DC, Chesnut CH 3rd, Gundberg CM, Hochberg MC, Klee G, Kleerekoper M, Watts NB, Bell NH. Looker AC, et al. Among authors: watts nb. Osteoporos Int. 2000;11(6):467-80. doi: 10.1007/s001980070088. Osteoporos Int. 2000. PMID: 10982161 Review.

5

Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.

Watts NB, Jenkins DK, Visor JM, Casal DC, Geusens P. Watts NB, et al. Osteoporos Int. 2001;12(4):279-88. doi: 10.1007/s001980170117. Osteoporos Int. 2001. PMID: 11420777 Clinical Trial.

6

Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials.

Watts NB. Watts NB. Osteoporos Int. 2001 Dec;12 Suppl 3:S17-22. doi: 10.1007/pl00014037. Osteoporos Int. 2001. PMID: 11846337 Review.

7

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.

Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, Santora AC 2nd, Kaur A, Peverly CA, Orloff JJ; Alendronate Once-Weekly Study Group. Rizzoli R, et al. Among authors: watts nb. J Bone Miner Res. 2002 Nov;17(11):1988-96. doi: 10.1359/jbmr.2002.17.11.1988. J Bone Miner Res. 2002. PMID: 12412806 Free article. Clinical Trial.

8

Risedronate prevents new vertebral fractures in postmenopausal women at high risk.

Watts NB, Josse RG, Hamdy RC, Hughes RA, Manhart MD, Barton I, Calligeros D, Felsenberg D. Watts NB, et al. J Clin Endocrinol Metab. 2003 Feb;88(2):542-9. doi: 10.1210/jc.2002-020400. J Clin Endocrinol Metab. 2003. PMID: 12574177 Clinical Trial.

9

Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate.

Watts NB, Lindsay R, Li Z, Kasibhatla C, Brown J. Watts NB, et al. Osteoporos Int. 2003 Jun;14(5):437-41. doi: 10.1007/s00198-003-1401-8. Epub 2003 Apr 29. Osteoporos Int. 2003. PMID: 12730756 Clinical Trial.

10

Bisphosphonate treatment of osteoporosis.

Watts NB. Watts NB. Clin Geriatr Med. 2003 May;19(2):395-414. doi: 10.1016/s0749-0690(02)00069-1. Clin Geriatr Med. 2003. PMID: 12916293 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters